BSE Live
Mar 04, 16:01Prev. Close
171.45
Open Price
165.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 04, 15:59Prev. Close
171.34
Open Price
167.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
171.21 (411)
| Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -10.04 | -8.36 | 15.42 | 6.79 | 0.00 | |
| Net CashFlow From Operating Activities | 16.92 | 20.02 | 23.15 | -36.06 | 0.00 | |
| Net Cash Used In Investing Activities | -35.33 | -118.05 | -134.09 | -12.72 | 0.00 | |
| Net Cash Used From Financing Activities | 31.56 | 58.78 | 13.84 | 9.86 | 0.00 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 13.16 | -39.24 | -97.10 | -38.92 | 0.00 | |
| Cash And Cash Equivalents Begin of Year | 22.34 | 61.59 | 158.69 | 197.61 | 0.00 | |
| Cash And Cash Equivalents End Of Year | 35.50 | 22.34 | 61.59 | 158.69 | 0.00 |
10.02.2026
Marksans Pharma Consolidated December 2025 Net Sales at Rs 754.43 crore, up 10.64% Y-o-Y
09.02.2026
Buy Marksans Pharma; target of Rs 225: Choice Institutional Equities
09.02.2026
Marksans Pharma Standalone December 2025 Net Sales at Rs 339.73 crore, up 8.93% Y-o-Y
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
10.02.2026
Marksans Pharma Consolidated December 2025 Net Sales at Rs 754.43 crore, up 10.64% Y-o-Y
09.02.2026
Marksans Pharma Standalone December 2025 Net Sales at Rs 339.73 crore, up 8.93% Y-o-Y
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y